Survodutide is a dual GLP-1 and glucagon receptor agonist designed to support weight loss and improve metabolic health.
Overview
Survodutide acts by mimicking two key hormones: GLP-1 (glucagon-like peptide-1) and glucagon. GLP-1 reduces appetite, delays gastric emptying, and promotes a feeling of fullness, which helps reduce calorie intake. This mechanism helps individuals manage their weight more effectively, especially in cases of obesity or type 2 diabetes.
In parallel, the glucagon receptor activation boosts energy expenditure by increasing metabolic activity. This dual-action approach helps burn fat while also preserving muscle mass. The combination of appetite suppression and increased metabolism makes Survodutide effective in achieving sustained weight loss and improving blood sugar levels.
Key Benefits
Survodutide offers multiple benefits, especially for people dealing with obesity or type 2 diabetes. It helps lower body weight, improves insulin sensitivity, and may support better blood sugar control. Clinical trials also suggest it can reduce liver fat, making it useful for patients with metabolic-associated fatty liver disease (MAFLD).
Reviews
There are no reviews yet.